delta-valerolactone has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carta, F; Maresca, A; Scozzafava, A; Supuran, CT | 1 |
| Jagadeeshan, S; Kumar, GS; Nair K, L; Nair, SA | 1 |
2 other study(ies) available for delta-valerolactone and Neoplasms
| Article | Year |
|---|---|
5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors.
Topics: Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Chemistry, Pharmaceutical; Coumarins; Drug Design; Enzyme Inhibitors; Humans; Kinetics; Lactones; Models, Chemical; Neoplasms; Prodrugs; Protein Isoforms | 2012 |
Evaluation of triblock copolymeric micelles of δ- valerolactone and poly (ethylene glycol) as a competent vector for doxorubicin delivery against cancer.
Topics: Annexin A5; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Doxorubicin; Drug Carriers; G2 Phase Cell Cycle Checkpoints; Humans; Micelles; Neoplasms; Poly(ADP-ribose) Polymerases; Polyethylene Glycols; Polymers; Pyrones | 2011 |